Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Succinic semialdehyde dehydrogenase deficiency: lessons from mice and men.

Pearl PL, Gibson KM, Cortez MA, Wu Y, Carter Snead O 3rd, Knerr I, Forester K, Pettiford JM, Jakobs C, Theodore WH.

J Inherit Metab Dis. 2009 Jun;32(3):343-52. doi: 10.1007/s10545-009-1034-y. Epub 2009 Jan 28. Review.

2.

Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development.

Jansen EE, Struys E, Jakobs C, Hager E, Snead OC, Gibson KM.

BMC Dev Biol. 2008 Nov 28;8:112. doi: 10.1186/1471-213X-8-112.

3.

NKCC1 cotransporter inactivation underlies embryonic development of chloride-mediated inhibition in mouse spinal motoneuron.

Delpy A, Allain AE, Meyrand P, Branchereau P.

J Physiol. 2008 Feb 15;586(4):1059-75. Epub 2007 Dec 20.

4.

Strain-dependent effects of SGS742 in the mouse.

Sunyer B, Patil S, Frischer C, Höger H, Selcher J, Brannath W, Lubec G.

Behav Brain Res. 2007 Jul 19;181(1):64-75. Epub 2007 Mar 30.

PMID:
17467069
5.

A GABAA receptor mutation causing generalized epilepsy reduces benzodiazepine receptor binding.

Fedi M, Berkovic SF, Marini C, Mulligan R, Tochon-Danguy H, Reutens DC.

Neuroimage. 2006 Sep;32(3):995-1000. Epub 2006 Jul 27.

PMID:
16875845
6.

Succinic semialdehyde dehydrogenase deficiency: GABAB receptor-mediated function.

Buzzi A, Wu Y, Frantseva MV, Perez Velazquez JL, Cortez MA, Liu CC, Shen LQ, Gibson KM, Snead OC 3rd.

Brain Res. 2006 May 23;1090(1):15-22. Epub 2006 May 2.

PMID:
16647690
7.

Increased guanidino species in murine and human succinate semialdehyde dehydrogenase (SSADH) deficiency.

Jansen EE, Verhoeven NM, Jakobs C, Schulze A, Senephansiri H, Gupta M, Snead OC, Gibson KM.

Biochim Biophys Acta. 2006 Apr;1762(4):494-8. Epub 2006 Feb 10.

9.

Succinate semialdehyde dehydrogenase deficiency does not down-regulate gamma-hydroxybutyric acid binding sites in the mouse brain.

Mehta AK, Gould GG, Gupta M, Carter LP, Gibson KM, Ticku MK.

Mol Genet Metab. 2006 May;88(1):86-9. Epub 2006 Jan 10.

PMID:
16406647
10.

A novel, quantitative assay for homocarnosine in cerebrospinal fluid using stable-isotope dilution liquid chromatography-tandem mass spectrometry.

Jansen EE, Gibson KM, Shigematsu Y, Jakobs C, Verhoeven NM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jan 18;830(2):196-200. Epub 2005 Nov 22.

PMID:
16309980
11.

Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor-mediated mechanisms.

Wu Y, Buzzi A, Frantseva M, Velazquez JP, Cortez M, Liu C, Shen L, Gibson KM, Snead OC 3rd.

Ann Neurol. 2006 Jan;59(1):42-52.

PMID:
16240371
12.

5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction.

Giovacchini G, Toczek MT, Bonwetsch R, Bagic A, Lang L, Fraser C, Reeves-Tyer P, Herscovitch P, Eckelman WC, Carson RE, Theodore WH.

J Nucl Med. 2005 Jul;46(7):1128-35.

13.

Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy.

Cortez MA, Wu Y, Gibson KM, Snead OC 3rd.

Pharmacol Biochem Behav. 2004 Nov;79(3):547-53.

PMID:
15582027
14.

Seizure evolution and amino acid imbalances in murine succinate semialdehyde dehydrogenase (SSADH) deficiency.

Gupta M, Polinsky M, Senephansiri H, Snead OC, Jansen EE, Jakobs C, Gibson KM.

Neurobiol Dis. 2004 Aug;16(3):556-62.

PMID:
15262267
15.

Proton MR spectroscopy in succinic semialdehyde dehydrogenase deficiency.

Ethofer T, Seeger U, Klose U, Erb M, Kardatzki B, Kraft E, Landwehrmeyer GB, Grodd W, Storch A.

Neurology. 2004 Mar 23;62(6):1016-8.

PMID:
15037717
16.
17.

Clinical spectrum of succinic semialdehyde dehydrogenase deficiency.

Pearl PL, Gibson KM, Acosta MT, Vezina LG, Theodore WH, Rogawski MA, Novotny EJ, Gropman A, Conry JA, Berry GT, Tuchman M.

Neurology. 2003 May 13;60(9):1413-7.

PMID:
12743223
18.

Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging.

Wu Y, Carson RE.

J Cereb Blood Flow Metab. 2002 Dec;22(12):1440-52.

PMID:
12468889
19.

New agents for sedation in the intensive care unit.

Maze M, Scarfini C, Cavaliere F.

Crit Care Clin. 2001 Oct;17(4):881-97. Review.

PMID:
11762266
20.

Prolonged vigabatrin treatment modifies developmental changes of GABA(A)-receptor binding in young children with epilepsy.

Juhász C, Muzik O, Chugani DC, Shen C, Janisse J, Chugani HT.

Epilepsia. 2001 Oct;42(10):1320-6.

Supplemental Content

Support Center